Compare EHang Holdings Ltd - ADR (EH) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Vaxcyte Inc. Common Stock — how do they compare? EHang Holdings Ltd - ADR trades at $3.77 (market cap $286.70M), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.63B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 37.1× EHang Holdings Ltd - ADR's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EHang Holdings Ltd - ADR for 47 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| EH | PCVX | |
|---|---|---|
Market Cap | $286.70M | $10.63B |
Volume | 653,613 | 1,525,205 |
Sector | Industrials | Health |
52-Week High | $18.94 | $73.82 |
52-Week Low | $3.78 | $40.32 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $238.30M | $9.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $3.82, down 3.78% today, reflecting ongoing investor concerns. The stock shows bearish technical signals with negative moving averages, while fundamentals reveal persistent losses despite revenue growth. Recent news includes both positive business expansion in Vietnam and multiple law firm investigations into investor claims, creating mixed sentiment. The company maintains a strong cash position of $1.12 billion but faces significant profitability challenges with a -91.28% net income margin.
Outlook remains challenging with widening losses projected for 2026 and regulatory uncertainties. The stock presents high-risk speculative potential for investors betting on eVTOL adoption, but current financial performance and legal scrutiny warrant caution. Analyst consensus is divided with 20% buy, 40% hold, and 40% sell ratings, reflecting the polarized view on EHang's future prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
